Stonehage Fleming Financial Services’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$449K Hold
1,766
0.02% 122
2026
Q1
$432K Hold
1,766
0.02% 124
2025
Q4
$365K Sell
1,766
-1,043
-37% -$206K 0.01% 118
2025
Q3
$521K Hold
2,809
0.01% 98
2025
Q2
$429K Hold
2,809
0.01% 114
2025
Q1
$466K Hold
2,809
0.02% 94
2024
Q4
$406K Hold
2,809
0.01% 112
2024
Q3
$455K Hold
2,809
0.01% 108
2024
Q2
$411K Sell
2,809
-10,285
-79% -$1.53M 0.01% 106
2024
Q1
$2.04M Buy
13,094
+8,776
+203% +$1.4M 0.13% 26
2023
Q4
$677K Sell
4,318
-6,460
-60% -$991K 0.02% 78
2023
Q3
$1.68M Sell
10,778
-2,316
-18% -$382K 0.15% 49
2023
Q2
$2.17M Hold
13,094
0.08% 41
2023
Q1
$2.04M Buy
13,094
+2,447
+23% +$395K 0.13% 26
2022
Q4
$1.88M Sell
10,647
-1,220
-10% -$211K 0.14% 28
2022
Q3
$1.94M Buy
11,867
+90
+0.8% +$15.2K 0.15% 26
2022
Q2
$2.09M Buy
11,777
+5,321
+82% +$948K 0.08% 43
2022
Q1
$1.14M Buy
6,456
+2,264
+54% +$385K 0.04% 71
2021
Q4
$716K Buy
4,192
+69
+2% +$11.3K 0.02% 98
2021
Q3
$666K Sell
4,123
-600
-13% -$102K 0.02% 96
2021
Q2
$778K Hold
4,723
0.02% 92
2021
Q1
$776K Sell
4,723
-6,175
-57% -$999K 0.03% 94
2020
Q4
$1.72M Sell
10,898
-200
-2% -$29.5K 0.06% 60
2020
Q3
$1.65M Buy
11,098
+2,123
+24% +$314K 0.06% 50
2020
Q2
$1.26M Buy
8,975
+1,402
+19% +$204K 0.09% 46
2020
Q1
$993K Sell
7,573
-3,524
-32% -$500K 0.05% 55
2019
Q4
$1.62M Buy
11,097
+2,974
+37% +$403K 0.07% 46
2019
Q3
$1.05M Buy
8,123
+3,915
+93% +$516K 0.05% 62
2019
Q2
$586K Sell
4,208
-30,335
-88% -$4.2M 0.03% 79
2019
Q1
$4.83K Sell
34,543
-1,139
-3% -$153K 0.22% 32
2018
Q4
$4.6M Sell
35,682
-4,142
-10% -$578K 0.26% 30
2018
Q3
$5.49M Sell
39,824
-43,512
-52% -$5.78M 0.32% 26
2018
Q2
$10.1M Buy
83,336
+41,299
+98% +$5.15M 0.47% 28
2018
Q1
$5.39M Sell
42,037
-30,328
-42% -$4.1M 0.35% 29
2017
Q4
$10.1M Sell
72,365
-43,014
-37% -$5.99M 0.55% 29
2017
Q3
$15M Buy
115,379
+31,579
+38% +$4.19M 0.73% 26
2017
Q2
$11.1M Buy
83,800
+110
+0.1% +$14K 0.67% 27
2017
Q1
$10.4M Buy
83,690
+1,560
+2% +$186K 0.67% 31
2016
Q4
$9.46M Buy
82,130
+324
+0.4% +$37.4K 0.59% 32
2016
Q3
$9.66M Sell
81,806
-1,664
-2% -$202K 0.57% 33
2016
Q2
$10.1M Sell
83,470
-2,503
-3% -$284K 0.67% 31
2016
Q1
$9.3M Sell
85,973
-40,628
-32% -$4.21M 0.61% 31
2015
Q4
$13M Buy
126,601
+16,851
+15% +$1.69M 1.06% 25
2015
Q3
$10.2M Sell
109,750
-42,012
-28% -$4.06M 1.09% 24
2015
Q2
$14.8M Sell
151,762
-13,022
-8% -$1.3M 1.77% 18
2015
Q1
$16.6M Sell
164,784
-68,850
-29% -$7M 1.98% 18
2014
Q4
$24.4M Buy
+233,634
New +$24.6M 2.91% 13

Other funds holding JNJ

Stonehage Fleming Financial Services's JNJ Position: Q2 2026 in Review

Stonehage Fleming Financial Services held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 1,766 shares worth $449K. The position accounts for 0.02% of the portfolio, ranked #122.

Stonehage Fleming Financial Services first reported a position in JNJ in Q4 2014 and has held it in 47 quarters since. The position peaked at $24.4M in Q4 2014. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Stonehage Fleming Financial Services held 1,766 shares of Johnson & Johnson worth $449K as of Q2 2026.
  • Stonehage Fleming Financial Services left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 0.02% of Stonehage Fleming Financial Services's portfolio in Q2 2026, its #122 holding.
  • Stonehage Fleming Financial Services first reported a position in Johnson & Johnson in Q4 2014 and has held it in 47 quarters since.
  • Stonehage Fleming Financial Services's Johnson & Johnson position peaked at $24.4M in Q4 2014.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Stonehage Fleming Financial Services's 13F filing for Q2 2026, filed 17 Aug 2026.